Option Care Health (NASDAQ:OPCH) Price Target Raised to $33.00 at Barrington Research

Option Care Health (NASDAQ:OPCH) had its price objective hoisted by Barrington Research from $32.00 to $33.00 in a report released on Tuesday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock. Barrington Research also issued estimates for Option Care Health’s Q1 2025 earnings at $0.22 EPS, Q2 2025 earnings at $0.30 EPS, Q3 2025 earnings at $0.32 EPS, Q4 2025 earnings at $0.36 EPS, FY2025 earnings at $1.20 EPS and FY2026 earnings at $1.42 EPS.

A number of other research analysts also recently commented on the company. JMP Securities reiterated a “market outperform” rating and set a $30.00 target price (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and lowered their price objective for the company from $38.00 to $26.00 in a research report on Thursday, October 31st. The Goldman Sachs Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their target price for the company from $26.00 to $33.00 in a research report on Monday. Finally, Truist Financial dropped their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $29.86.

Option Care Health Trading Up 1.9 %

Shares of OPCH stock opened at $29.32 on Tuesday. The stock’s 50-day moving average price is $23.44 and its 200-day moving average price is $27.71. Option Care Health has a 12-month low of $21.39 and a 12-month high of $34.63. The stock has a market capitalization of $4.99 billion, a price-to-earnings ratio of 24.64, a price-to-earnings-growth ratio of 2.44 and a beta of 1.31. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.

Insider Transactions at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the business’s stock in a transaction dated Friday, November 8th. The shares were purchased at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the purchase, the director now owns 326,334 shares in the company, valued at $7,355,568.36. This represents a 15.18 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 0.64% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

Large investors have recently bought and sold shares of the business. UMB Bank n.a. increased its stake in Option Care Health by 937.5% in the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after purchasing an additional 750 shares during the period. GAMMA Investing LLC grew its holdings in shares of Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after purchasing an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. increased its stake in Option Care Health by 3,362.8% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after buying an additional 1,446 shares during the period. International Assets Investment Management LLC lifted its holdings in Option Care Health by 3,029.7% during the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after buying an additional 2,757 shares in the last quarter. Finally, Quarry LP boosted its position in Option Care Health by 327.7% in the 3rd quarter. Quarry LP now owns 3,430 shares of the company’s stock valued at $107,000 after buying an additional 2,628 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.